Cargando…

A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriuria

IMPORTANCE: Hospitalized patients with asymptomatic bacteriuria (ASB) often receive unnecessary antibiotic treatment, which increases antibiotic resistance and adverse events. OBJECTIVE: To determine whether diagnostic stewardship (avoiding unnecessary urine cultures) or antibiotic stewardship (redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaughn, Valerie M., Gupta, Ashwin, Petty, Lindsay A., Malani, Anurag N., Osterholzer, Danielle, Patel, Payal K., Younas, Mariam, Bernstein, Steven J., Burdick, Stephanie, Ratz, David, Szymczak, Julia E., McLaughlin, Elizabeth, Czilok, Tawny, Basu, Tanima, Horowitz, Jennifer K., Flanders, Scott A., Gandhi, Tejal N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334295/
https://www.ncbi.nlm.nih.gov/pubmed/37428491
http://dx.doi.org/10.1001/jamainternmed.2023.2749
_version_ 1785070828921028608
author Vaughn, Valerie M.
Gupta, Ashwin
Petty, Lindsay A.
Malani, Anurag N.
Osterholzer, Danielle
Patel, Payal K.
Younas, Mariam
Bernstein, Steven J.
Burdick, Stephanie
Ratz, David
Szymczak, Julia E.
McLaughlin, Elizabeth
Czilok, Tawny
Basu, Tanima
Horowitz, Jennifer K.
Flanders, Scott A.
Gandhi, Tejal N.
author_facet Vaughn, Valerie M.
Gupta, Ashwin
Petty, Lindsay A.
Malani, Anurag N.
Osterholzer, Danielle
Patel, Payal K.
Younas, Mariam
Bernstein, Steven J.
Burdick, Stephanie
Ratz, David
Szymczak, Julia E.
McLaughlin, Elizabeth
Czilok, Tawny
Basu, Tanima
Horowitz, Jennifer K.
Flanders, Scott A.
Gandhi, Tejal N.
author_sort Vaughn, Valerie M.
collection PubMed
description IMPORTANCE: Hospitalized patients with asymptomatic bacteriuria (ASB) often receive unnecessary antibiotic treatment, which increases antibiotic resistance and adverse events. OBJECTIVE: To determine whether diagnostic stewardship (avoiding unnecessary urine cultures) or antibiotic stewardship (reducing unnecessary antibiotic treatment after an unnecessary culture) is associated with better outcomes in reducing antibiotic use for ASB. DESIGN, SETTING, AND PARTICIPANTS: This 3-year, prospective quality improvement study included hospitalized general care medicine patients with a positive urine culture among 46 hospitals participating in a collaborative quality initiative, the Michigan Hospital Medicine Safety Consortium. Data were collected from July 1, 2017, through March 31, 2020, and analyzed from February to October 2022. EXPOSURE: Participation in the Michigan Hospital Medicine Safety Consortium with antibiotic and diagnostic stewardship strategies at hospital discretion. MAIN OUTCOMES AND MEASURES: Overall improvement in ASB-related antibiotic use was estimated as change in percentage of patients treated with antibiotics who had ASB. Effect of diagnostic stewardship was estimated as change in percentage of patients with a positive urine culture who had ASB. Effect of antibiotic stewardship was estimated as change in percentage of patients with ASB who received antibiotics and antibiotic duration. RESULTS: Of the 14 572 patients with a positive urine culture included in the study (median [IQR] age, 75.8 [64.2-85.1] years; 70.5% female); 28.4% (n = 4134) had ASB, of whom 76.8% (n = 3175) received antibiotics. Over the study period, the percentage of patients treated with antibiotics who had ASB (overall ASB-related antibiotic use) declined from 29.1% (95% CI, 26.2%-32.2%) to 17.1% (95% CI, 14.3%-20.2%) (adjusted odds ratio [aOR], 0.94 per quarter; 95% CI, 0.92-0.96). The percentage of patients with a positive urine culture who had ASB (diagnostic stewardship metric) declined from 34.1% (95% CI, 31.0%-37.3%) to 22.5% (95% CI, 19.7%-25.6%) (aOR, 0.95 per quarter; 95% CI, 0.93-0.97). The percentage of patients with ASB who received antibiotics (antibiotic stewardship metric) remained stable, from 82.0% (95% CI, 77.7%-85.6%) to 76.3% (95% CI, 68.5%-82.6%) (aOR, 0.97 per quarter; 95% CI, 0.94-1.01), as did adjusted mean antibiotic duration, from 6.38 (95% CI, 6.00-6.78) days to 5.93 (95% CI, 5.54-6.35) days (adjusted incidence rate ratio, 0.99 per quarter; 95% CI, 0.99-1.00). CONCLUSIONS AND RELEVANCE: This quality improvement study showed that over 3 years, ASB-related antibiotic use decreased and was associated with a decline in unnecessary urine cultures. Hospitals should prioritize reducing unnecessary urine cultures (ie, diagnostic stewardship) to reduce antibiotic treatment related to ASB.
format Online
Article
Text
id pubmed-10334295
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-103342952023-07-12 A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriuria Vaughn, Valerie M. Gupta, Ashwin Petty, Lindsay A. Malani, Anurag N. Osterholzer, Danielle Patel, Payal K. Younas, Mariam Bernstein, Steven J. Burdick, Stephanie Ratz, David Szymczak, Julia E. McLaughlin, Elizabeth Czilok, Tawny Basu, Tanima Horowitz, Jennifer K. Flanders, Scott A. Gandhi, Tejal N. JAMA Intern Med Original Investigation IMPORTANCE: Hospitalized patients with asymptomatic bacteriuria (ASB) often receive unnecessary antibiotic treatment, which increases antibiotic resistance and adverse events. OBJECTIVE: To determine whether diagnostic stewardship (avoiding unnecessary urine cultures) or antibiotic stewardship (reducing unnecessary antibiotic treatment after an unnecessary culture) is associated with better outcomes in reducing antibiotic use for ASB. DESIGN, SETTING, AND PARTICIPANTS: This 3-year, prospective quality improvement study included hospitalized general care medicine patients with a positive urine culture among 46 hospitals participating in a collaborative quality initiative, the Michigan Hospital Medicine Safety Consortium. Data were collected from July 1, 2017, through March 31, 2020, and analyzed from February to October 2022. EXPOSURE: Participation in the Michigan Hospital Medicine Safety Consortium with antibiotic and diagnostic stewardship strategies at hospital discretion. MAIN OUTCOMES AND MEASURES: Overall improvement in ASB-related antibiotic use was estimated as change in percentage of patients treated with antibiotics who had ASB. Effect of diagnostic stewardship was estimated as change in percentage of patients with a positive urine culture who had ASB. Effect of antibiotic stewardship was estimated as change in percentage of patients with ASB who received antibiotics and antibiotic duration. RESULTS: Of the 14 572 patients with a positive urine culture included in the study (median [IQR] age, 75.8 [64.2-85.1] years; 70.5% female); 28.4% (n = 4134) had ASB, of whom 76.8% (n = 3175) received antibiotics. Over the study period, the percentage of patients treated with antibiotics who had ASB (overall ASB-related antibiotic use) declined from 29.1% (95% CI, 26.2%-32.2%) to 17.1% (95% CI, 14.3%-20.2%) (adjusted odds ratio [aOR], 0.94 per quarter; 95% CI, 0.92-0.96). The percentage of patients with a positive urine culture who had ASB (diagnostic stewardship metric) declined from 34.1% (95% CI, 31.0%-37.3%) to 22.5% (95% CI, 19.7%-25.6%) (aOR, 0.95 per quarter; 95% CI, 0.93-0.97). The percentage of patients with ASB who received antibiotics (antibiotic stewardship metric) remained stable, from 82.0% (95% CI, 77.7%-85.6%) to 76.3% (95% CI, 68.5%-82.6%) (aOR, 0.97 per quarter; 95% CI, 0.94-1.01), as did adjusted mean antibiotic duration, from 6.38 (95% CI, 6.00-6.78) days to 5.93 (95% CI, 5.54-6.35) days (adjusted incidence rate ratio, 0.99 per quarter; 95% CI, 0.99-1.00). CONCLUSIONS AND RELEVANCE: This quality improvement study showed that over 3 years, ASB-related antibiotic use decreased and was associated with a decline in unnecessary urine cultures. Hospitals should prioritize reducing unnecessary urine cultures (ie, diagnostic stewardship) to reduce antibiotic treatment related to ASB. American Medical Association 2023-07-10 2023-09 /pmc/articles/PMC10334295/ /pubmed/37428491 http://dx.doi.org/10.1001/jamainternmed.2023.2749 Text en Copyright 2023 Vaughn VM et al. JAMA Internal Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Vaughn, Valerie M.
Gupta, Ashwin
Petty, Lindsay A.
Malani, Anurag N.
Osterholzer, Danielle
Patel, Payal K.
Younas, Mariam
Bernstein, Steven J.
Burdick, Stephanie
Ratz, David
Szymczak, Julia E.
McLaughlin, Elizabeth
Czilok, Tawny
Basu, Tanima
Horowitz, Jennifer K.
Flanders, Scott A.
Gandhi, Tejal N.
A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriuria
title A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriuria
title_full A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriuria
title_fullStr A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriuria
title_full_unstemmed A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriuria
title_short A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriuria
title_sort statewide quality initiative to reduce unnecessary antibiotic treatment of asymptomatic bacteriuria
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334295/
https://www.ncbi.nlm.nih.gov/pubmed/37428491
http://dx.doi.org/10.1001/jamainternmed.2023.2749
work_keys_str_mv AT vaughnvaleriem astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT guptaashwin astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT pettylindsaya astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT malanianuragn astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT osterholzerdanielle astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT patelpayalk astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT younasmariam astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT bernsteinstevenj astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT burdickstephanie astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT ratzdavid astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT szymczakjuliae astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT mclaughlinelizabeth astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT cziloktawny astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT basutanima astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT horowitzjenniferk astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT flandersscotta astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT gandhitejaln astatewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT vaughnvaleriem statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT guptaashwin statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT pettylindsaya statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT malanianuragn statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT osterholzerdanielle statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT patelpayalk statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT younasmariam statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT bernsteinstevenj statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT burdickstephanie statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT ratzdavid statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT szymczakjuliae statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT mclaughlinelizabeth statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT cziloktawny statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT basutanima statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT horowitzjenniferk statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT flandersscotta statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria
AT gandhitejaln statewidequalityinitiativetoreduceunnecessaryantibiotictreatmentofasymptomaticbacteriuria